These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20832890)
1. CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. Nijkamp MW; Hoogwater FJ; Steller EJ; Westendorp BF; van der Meulen TA; Leenders MW; Borel Rinkes IH; Kranenburg O J Hepatol; 2010 Dec; 53(6):1069-77. PubMed ID: 20832890 [TBL] [Abstract][Full Text] [Related]
2. Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation. Govaert KM; Nijkamp MW; Emmink BL; Steller EJ; Minchinton AI; Kranenburg O; Borel Rinkes IH Br J Surg; 2012 Apr; 99(4):567-75. PubMed ID: 22331808 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells. Govaert KM; Emmink BL; Nijkamp MW; Cheung ZJ; Steller EJ; Fatrai S; de Bruijn MT; Kranenburg O; Borel Rinkes IH Ann Surg; 2014 Apr; 259(4):750-9. PubMed ID: 24253142 [TBL] [Abstract][Full Text] [Related]
4. Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Nijkamp MW; van der Bilt JD; de Bruijn MT; Molenaar IQ; Voest EE; van Diest PJ; Kranenburg O; Borel Rinkes IH Ann Surg; 2009 May; 249(5):814-23. PubMed ID: 19387320 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. Nijkamp MW; Borren A; Govaert KM; Hoogwater FJ; Molenaar IQ; van Diest PJ; Kranenburg O; Borel Rinkes IH J Surg Oncol; 2010 Jun; 101(7):551-6. PubMed ID: 20461760 [TBL] [Abstract][Full Text] [Related]
7. A role for CD95 signaling in ischemia/reperfusion-induced invasion and outgrowth of colorectal micrometastases in mouse liver. Nijkamp MW; Hoogwater FJ; Govaert KM; Steller EJ; Verheem A; Kranenburg O; Borel Rinkes IH J Surg Oncol; 2011 Aug; 104(2):198-204. PubMed ID: 21506133 [TBL] [Abstract][Full Text] [Related]
8. The role of CD95 and CD95 ligand in cancer. Peter ME; Hadji A; Murmann AE; Brockway S; Putzbach W; Pattanayak A; Ceppi P Cell Death Differ; 2015 Apr; 22(4):549-59. PubMed ID: 25656654 [TBL] [Abstract][Full Text] [Related]
9. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794 [TBL] [Abstract][Full Text] [Related]
10. CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells. Reinehr R; Sommerfeld A; Häussinger D Gastroenterology; 2008 May; 134(5):1494-506. PubMed ID: 18471522 [TBL] [Abstract][Full Text] [Related]
11. Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro. Merz C; Strecker A; Sykora J; Hill O; Fricke H; Angel P; Gieffers C; Peterziel H Anticancer Drugs; 2015 Aug; 26(7):716-27. PubMed ID: 25850884 [TBL] [Abstract][Full Text] [Related]
12. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system. Schlosser SF; Azzaroli F; Dao T; Hingorani R; Crispe IN; Boyer JL Hepatology; 2000 Oct; 32(4 Pt 1):779-85. PubMed ID: 11003622 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Hoogwater FJ; Nijkamp MW; Smakman N; Steller EJ; Emmink BL; Westendorp BF; Raats DA; Sprick MR; Schaefer U; Van Houdt WJ; De Bruijn MT; Schackmann RC; Derksen PW; Medema JP; Walczak H; Borel Rinkes IH; Kranenburg O Gastroenterology; 2010 Jun; 138(7):2357-67. PubMed ID: 20188103 [TBL] [Abstract][Full Text] [Related]
14. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Zuliani C; Kleber S; Klussmann S; Wenger T; Kenzelmann M; Schreglmann N; Martinez A; del Rio JA; Soriano E; Vodrazka P; Kuner R; Groene HJ; Herr I; Krammer PH; Martin-Villalba A Cell Death Differ; 2006 Jan; 13(1):31-40. PubMed ID: 16003386 [TBL] [Abstract][Full Text] [Related]
15. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand. Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases. Smakman N; Kranenburg O; Vogten JM; Bloemendaal AL; van Diest P; Borel Rinkes IH Clin Cancer Res; 2005 Jan; 11(1):41-8. PubMed ID: 15671526 [TBL] [Abstract][Full Text] [Related]
17. Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model. Liao H; Ahmed M; Markezana A; Zeng G; Stechele M; Galun E; Goldberg SN Radiology; 2020 Feb; 294(2):464-472. PubMed ID: 31845846 [TBL] [Abstract][Full Text] [Related]
18. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion. Yoong KF; Afford SC; Randhawa S; Hubscher SG; Adams DH Am J Pathol; 1999 Mar; 154(3):693-703. PubMed ID: 10079247 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit. Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076 [TBL] [Abstract][Full Text] [Related]
20. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis. Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]